Lisa A Kachnic

9PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyOncology and carcinogenesis not elsewhere classifiedGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 15, 2026
Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.

|Mar 11, 2026
Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma.

Lisa A Kachnic, Jennifer Moughan, Theodore S Hong

|Aug 11, 2025
Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003.

Vinai Gondi, Stephanie L Pugh, Minesh P Mehta

|May 15, 2025
Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203.

Kelsey L Corrigan, Rebecca Paulus, Ann H Klopp

|Aug 08, 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.

Aaron J Scott, Erin B Kennedy, Jordan Berlin

|Jul 27, 2024
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery.

Lisa A Kachnic, Kathryn Winter, Mohan Suntharalingam

Pageof 2

Frequent Collaborators

3 joint publications

Vijayananda Kundapur

2 joint publications

Rebecca Paulus

2 joint publications

Abraham J Wu

2 joint publications

Michael L Haas